Cellnex currently manages a portfolio of 15,140 macro sites across Italy and Spain and with a large appetite for new acquisitions (following its 2015 IPO and acquisition of 7,377 sites from WIND in Italy). Their focus has expanded to also looking at opportunities in Europe’s small cells and DAS market. In this interview we speak with Cellnex’s International Business Development Manager, David Bernal to get a snapshot of Cellnex’s activity in the small cells and DAS market to date and where they forecast the business to be heading.
TowerXchange: Please can you provide an introduction to Cellnex’s experience in the small cells and DAS market?
David Bernal, Business Development Manager, Cellnex:
When it comes to small cells and DAS, we have different kinds of projects underway.
